Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group. - Lin, Ray S.; Mukhopadhyay, Pralay; Roychoudhury, Satrajit; Anderson, Keaven M.; Hu, Tianle; Huang, Bo; Leon, Larry F.; Liao, Jason J. Z.; Lin, Ji; Liu, Rong; Luo, Xiaodong; Mai, Yabing; et al. (Statistics in Biopharmaceutical Research, 2023)